Different Dosing Time of Bowklean for the Bowel Preparation
- Conditions
- Bowel Preparation
- Interventions
- Drug: Bowklean
- Registration Number
- NCT04483037
- Lead Sponsor
- Changhua Christian Hospital
- Brief Summary
The primary objective of this study is to compare the efficacy of administration routine bowel cleansing medication (Bowklean) for the Bowel Preparation at Different Times Prior Colonoscopy in the morning or in the afternoon.
- Detailed Description
Sodium picosulfate/magnesium citrate (SPMC) is a small-volume bowel cleansing agent with similar efficacy and better tolerability than polyethylene glycol. However, there was limited data about the bowel cleansing efficacy of SPMC in comparing the same-day and split-dose preparation for afternoon colonoscopy.
This randomized, single-center, endoscopist-blinded, non-inferior study compared same-day (101 subjects) and split-dose (96 subjects) preparation with SPMC for afternoon colonoscopy. One additional prospective observation group of 100 subjects receiving colonoscopy in the morning was included as an observation group to compare bowel preparation in morning and afternoon colonoscopy. Efficacy of bowel cleansing was evaluated by the Aronchick Scale, Ottawa Bowel Preparation Scale (OBPS), Boston Bowel Preparation Scale (BBPS), and the Bubble Scale (TBS).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 297
- Subject is 20 and 99 years, inclusive.
- Men or non-pregnant women who are scheduled for an elective colonoscopy.
- Subjects should be willing, able to complete the entire procedure and to comply with study instructions.
- Written informed consent obtained prior to study.
-
Patients who are not suitable for colonoscopy
- Acute surgical abdominal conditions (e.g. acute obstruction or perforation, etc.)
- Active (acute/exacerbation of/severe/uncontrolled) Inflammatory Bowel Disease (IBD)
- Colon disease (history of colonic cancer, toxic megacolon, toxic colitis, idiopathic pseudo- obstruction, hypomotility syndrome)
- Gastrointestinal disorder (active ulcer, outlet obstruction, gastric retention, gastroparesis, ileus)
- Uncontrolled angina and/or Myocardial Infarction (MI) within last 3 months before randomization, Congestive Heart Failure (CHF), arrhythmia, cardiomyopathy or uncontrolled hypertension
- Renal insufficiency
-
Any prior colorectal surgery
- in the past 3 months, excluding appendectomy, hemorrhoid surgery or prior endoscopic procedures
- History of upper gastrointestinal surgery (gastric resection, gastric banding, gastric by-pass)
-
Severe chronic constipation
-
Hypersensitivity to any ingredient in the study medication
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description split dose, day before, colonoscopy in the morning (Observation Group) Bowklean routine bowel preparation before colonoscopy in the morning split dose, day before, colonoscopy in the afternoon (Random) Bowklean routine bowel preparation before colonoscopy in the afternoon two dose in the same day, colonoscopy in the afternoon (Random) Bowklean experimental group
- Primary Outcome Measures
Name Time Method Aronchick Scale Bowel Cleaning Scale during colonoscopy Aroochick Scale ranges from score 1 : excellent, 2: good, 3: fair, 4: poor 5: failed
- Secondary Outcome Measures
Name Time Method Boston Bowel Preparation Scale (BBPS) Bowel Cleaning Scale During Colonoscopy The Boston Bowel Preparation Scale Score 0 : inadequate ; Score 1: fair ;Score 2: good; Score 3: excellent . min : 0 , max: 3
Colonscopy Bubble Scale During Colonoscopy Colon Bubble Scale : Grade A : no bubble , Grade B: little bubble , Grade C: bubble of half of the lumen , Grade D: bubble of entire lumen. Grade A means the best and Grade D means the worst.
Trial Locations
- Locations (1)
Hsu-Heng Yen
🇨🇳Changhua, Taiwan